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Summary  Human  norovirus  (NoV)  is  a  major  cause  of  acute  gastroenteritis  in  closed
settings  such  as  hospitals,  hotels  and  cruise  ships.  The  virus  survives  on  inanimate
surfaces  for  extended  periods  of  time,  and  environmental  contamination  has  been
implicated  in  its  transmission.  The  disinfection  of  contaminated  areas  is  important
in  controlling  the  spread  of  NoV  infections.  Neutral  solutions  of  electrochemically
activated  (ECA)-anolyte  have  been  shown  to  be  powerful  disinfectants  against  a
broad  range  of  bacterial  pathogens.  The  active  chemical  ingredient  is  hypochlorous
acid  (HOCl),  which  is  registered  as  an  approved  food  contact  surface  sanitizer  in  the
United  States  by  the  Environmental  Protection  Agency,  pursuant  to  40  CFR  180.940.
We  evaluated  the  antiviral  activity  of  Ecasol  (an  ECA-anolyte)  against  feline  cali-
civirus  (FCV),  a surrogate  of  NoV.  FCV  dried  on  plastic  surfaces  was  exposed  to
Ecasol  for  1,  2,  or  5  min.  After  exposure  to  Ecasol,  the  virus  titers  were  compared
with  untreated  controls  to  determine  the  virus  inactivation  efﬁcacy  after  different
contact  times.  Ecasol  was  found  to  decrease  the  FCV  titer  by  >5  log10 within  1  min
of  contact,  indicating  its  suitability  for  inactivation  of  NoV  on  surfaces.
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n  recent  years,  there  have  been  several  out-
reaks of  acute  gastroenteritis,  predominantly  in
losed settings,  including  institutionalized  hous-
ng, hotels  and  cruise  ships  [1].  Epidemiological
nvestigations  have  conﬁrmed  that  >95%  of  these
utbreaks,  especially  on  cruise  ships,  are  caused  by
 Sciences. Published by Elsevier Ltd. All rights reserved.
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uman  norovirus  (NoV)  [2].  NoV  is  a  non-enveloped,
ingle-stranded  RNA  virus  belonging  to  the  family
aliciviridae  and  is  one  of  the  most  common  causes
f acute  gastroenteritis  in  humans.  This  virus  is
hed in  high  concentrations  (up  to  11  log10 per  gram
f feces)  and  has  a  low  infectious  dose  of  <100
nfectious virus  particles  [3].  Environmental  con-
amination  has  been  implicated  in  the  transmission
f NoV  because  the  virus  is  able  to  survive  for  days
o months  on  different  types  of  surfaces  [4].
Cleaning and  disinfection  of  contaminated  sur-
aces are  important  procedures  for  controlling
utbreaks of  NoV  in  hospital  and  community  sett-
ngs [4].  Although  the  use  of  alcohol-based  hand
ubs has  been  promoted  to  control  the  spread
f infection,  alcohol  has  a  limited  effectiveness
n killing  NoV  [5].  Various  virucides  are  com-
only used  to  disinfect  fomites  and  environmental
ontact surfaces  implicated  in  NoV  outbreaks.
he material  safety  data  sheets  and  labels  for
hese virucidal  compounds  rarely  allow  for  their
erosolization,  spraying,  or  fogging  due  to  their
oxicity  and  adverse  health  effects  for  given  expo-
ure durations  and  concentrations.  Many  of  these
hemical  compounds,  such  as  sodium  hypochlo-
ite, chlorine  gas,  and  glutaraldehyde,  have  been
ssociated  with  occupational  illnesses.  For  exam-
le, exposure  to  glutaraldehyde  is  associated  with
ontact dermatitis  in  health  workers,  and  the  use
f quaternary  ammonium  compounds  has  been
ound  to  cause  occupational  asthma  in  users  [6,7].
or cases  in  which  aerosolization  is  approved,
he use  of  personal  protective  equipment  and
 self-contained  breathing  apparatus  is required,
hich  makes  the  use  of  these  compounds  difﬁ-
ult, especially  in  public  places  such  as  hospitals
r schools.
Ecasol  is  a  unique  electrochemically  activated
ECA)-neutral pH  anolyte,  which  consists  of  an
‘activated’’  solution,  produced  by  a process
eferred to  as  dilute  brine  electrolysis.  Based  on
araday’s  laws  of  electrolysis,  advanced  continu-
us process  ECA  membrane  cell  manufacturing  was
ioneered  in  the  1970s  in  the  former  Soviet  Union
8] and  was  then  advanced  to  its  current  form
y Trustwater  (Clonmel,  Ireland).  Ecasol  has  been
emonstrated  as  a  powerful  disinfectant  and  has
een shown  to  be  efﬁcacious  against  a  wide  range
f microorganisms  in  solution  and  when  sprayed  in
he air  [9,10].  Another  signiﬁcant  beneﬁt  of  Ecasol
s its  lack  of  toxicity  at  ready-to-use  (RTU)  concen-
rations.  It  is considered  safe  in  food  processing
pplications by  the  United  States  Food  and  Drug
dministration  [11].  In  dental  procedures,  Ecasol
as been  shown  to  have  no  adverse  effects  on
uman  oral  tissues  [12].
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ECA  technology  involves  the  generation  of  elec-
rochemically  activated  solutions  by  passing  a
arefully regulated  electric  current  through  a brine
olution in  specialized  electrode  compartments  and
eparating the  ions  according  to  charge.  Ecasol
s a positively  charged  solution  emerging  from
 Trustwater  generator.  It  is  a strong  oxidizing
olution, with  a  pH  of  7.0,  a redox  potential  of
1200 mV,  and  an  active  chlorine  content  of  approx-
mately  ∼700  mg  L−1. Hypochlorous  acid  (HOCL)  is
he major  component  of  Ecasol,  which  also  con-
ains free  radicals  and  a small  amount  of  sodium
hloride (NaCl).  As  the  free  radicals  gradually  lose
nergy and  reform  as  water,  HOCL  dissociates  into
ydrogen and  hypochlorite  ions,  which  eventually
evert to  NaCl  (<0.2%)  and  water  (>99.8%).  The
ater evaporates,  leaving  salt  crystals  that  can  be
emoved by  routine  cleaning.
We undertook  this  study  to  evaluate  the  effec-
iveness of  Ecasol  for  decontaminating  surfaces
ontaminated with  NoV.  Because  NoV  is  currently
on-cultivable in  vitro,  efﬁcacy  tests  of  disinfec-
ants  rely  on  the  use  of  surrogates,  e.g.,  feline
alicivirus (FCV)  or  murine  norovirus  (MNV).  In  this
tudy, we  used  FCV  as  a  surrogate  for  NoV.
aterials and methods
irus
train  255  of  FCV  was  propagated  in  Crandell-Reese
eline Kidney  (CRFK)  cells,  and  aliquots  of  the  virus
ere stored  at  −80 ◦C  until  use.
reparation of ECA anolyte
he  Ecasol  anolyte  solution  was  prepared  on  the  day
f the  test  using  a fully  automatic  ECA  device  (Trust-
ater model  AQ-50).  This  device  electrolyzes  dilute
rine solution  using  a membrane-type  electrolytic
ell controlled  to  produce  two  metastabilized
lectrolyte  streams  in  dynamic  equilibrium.  The
atholyte  stream  (AversolTM by  Trustwater)  has  a
igh pH  and  is  classiﬁed  as  an  amphoteric  sur-
actant,  having  reduced  surface  tension  and  mild
etergent-like  properties.  Trustwater’s  automated
rocess  uses  this  solution  to  maintain  the  Ecasol
tream  at  a  neutral  pH.  The  new  Ecasol  solution
as titrated  at  700  ppm  free  available  chlorine
FAC), with  a pH  of  6.7.  The  solution  was  deliv-
red to  the  lab  on  the  day  of  the  experiment  and
as used  immediately  upon  delivery,  with  a  time
rom solution  generation  to  lab  experimentation  of
pproximately  2 h.  The  stability  of  Ecasol  depends
422  Y. Chander  et  al.
Table  1  Inactivation  of  feline  calicivirus  by  Ecasol.a
Ecasol  concentration
(ppm)
Time  (min)  Virus  titer  (TCID50/0.1  mL)b Percent  virus
reduction
Control  Test
150 1 107.0 101.5 99.9996
2  106.75 101.5 99.9994
5 106.75 101.5 99.9994
500 1 106.875 101.5 99.9995
2 106.625 101.5 99.9992
5 106.75 101.5 99.9994
a The results are an average of three different experiments.
b Control, virus treated with PBS; test, virus treated with Ecasol.
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pupon  storage  conditions  because  it  can  lose  up  to
10% of  its  activity  within  3  weeks  of  generation  if  it
is not  stored  properly.
Surface decontamination test
Two  concentrations  of  Ecasol,  150  ppm  and  500  ppm
FAC, were  prepared  by  diluting  the  solution  with
deionized  water.  These  testing  concentrations  were
selected because  150  ppm  is  the  most  commonly
used concentration  for  food  contact  surface  sani-
tization,  based  on  the  recommendation  of  40CFR
180.940,  and  the  concentration  of  500  ppm  was
selected  because  Ecasol  is  a  known  sporocidal  at
this concentration.
The  test  was  performed  in  6-well  tissue  culture
plates, and  the  experiments  were  conducted  in
triplicate.  The  six  wells  of  the  plate  were  labeled
A through  F,  and  the  FCV  suspension  was  uni-
formly applied  to  the  bottom  of  the  six  wells  at
100 L/well.  The  inoculum  was  allowed  to  dry  for
30 min  at  room  temperature  (approximately  23 ◦C)
in a  type  II  biosafety  cabinet.  After  the  inoculum
dried, the  Ecasol  solution  was  added  to  wells  A—C
at 5 mL/well.  Wells  D—F  served  as  controls  for  each
treated  well  (well  D  for  well  A,  and  so  on),  with
5 mL  of  phosphate  buffered  saline  (PBS)  per  well.
The plate  was  incubated  at  room  temperature  on
an orbital  shaker  (at  120  rpm)  for  different  time
periods  (1,  2,  and  5  min  for  wells  A  and  D,  B  and
E, and  C  and  F,  respectively).  After  the  appropriate
contact times,  the  well  contents  were  immediately
diluted 10-fold  using  a  maintenance  medium  to  stop
Ecasol activity  at  the  indicated  times.  Serial  10-
fold dilutions  of  these  eluates  were  prepared  in
Eagle’s MEM,  followed  by  inoculation  of  CRFK  cells
grown  in  96-well  microtiter  plates,  using  four  wells
for each  test  dilution.  The  inoculated  plates  were
f
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incubated  at  37 ◦C  and  examined  daily  for  4  days
y microscope  for  FCV-induced  cytopathic  effects
CPE).  The  virus  titers  were  calculated  by the  Reed
nd Muench  method  [13],  and  the  log  reductions
ere calculated  by  comparing  the  titers  of  the
casol-treated wells  with  those  of  the  PBS-treated
ontrol wells.  To  determine  the  cytotoxicity  of  the
casol solution  to  the  CRFK  cells,  10-fold  serial  dilu-
ions of  Ecasol  prepared  in  Eagle’s  MEM  were  added
o monolayers  of  CRFK  cells  prepared  in  a 96-well
late (4  wells/dilution).  Each  concentration  of  Eca-
ol (150  ppm  and  500  ppm)  was  tested  in  separate
xperiments, and  each  experiment  was  performed
n triplicate.
esults and discussion
n  this  study,  we  evaluated  the  effectiveness  of
casol solution  for  the  disinfection  of  a plastic  sur-
ace contaminated  with  FCV.  To  the  best  of  our
nowledge,  this  is  the  ﬁrst  study  of  the  use  of
casol  for  the  disinfection  of  surfaces  contami-
ated with  a NoV  surrogate.  The  results  indicate
hat Ecasol  at  150  ppm  and  500  ppm  inactivated
5 log10 of  FCV  (>99.999%  reduction  in  virus  titer)
ithin 1  min  at  room  temperature  (Table  1).  There
as no  additional  reduction  in  virus  titer  when
he contact  time  was  increased  from  1 min  to
 min.
NoV  is  a  major  cause  of  acute  gastroenteritis
orldwide  because  of  its  low  infective  dose  and
ts ability  to  survive  on  inert  objects  for  extended
eriods of  time.  The  virus  can  be  transferred
rom contaminated  surfaces  to  other  inert  objects,
ncluding  faucets,  door  handles,  and  telephones.  It
s important  to  implement  proper  cleaning  and  dis-
nfecting procedures  that  eliminate  virus  particles
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rom  contaminated  surfaces.  However,  NoV  cannot
e cultured  in  a  laboratory  setting,  which  ham-
ers research  on  the  development  of  prevention
nd control  strategies.  To  overcome  this  problem,
CV has  widely  been  used  as  a  surrogate  for  NoV
ecause its  physicochemical  and  genetic  properties
re similar  to  those  of  NoV  [14].  FCV  is  a  respi-
atory virus  in  felines  and  is  susceptible  to  high
emperatures  [15].  Genogroup  V  murine  NoV  (MNV)
as recently  been  advanced  as  a  surrogate  for  NoV
ecause  it  is  morphologically  and  genetically  sim-
lar to  NoV  and  can  be  propagated  in  cell  cultures
16].
Many studies  have  reported  on  various  com-
ounds used  for  the  inactivation  of  FCV,  including
cids  and  alcohols  [17],  ozone  gas  [18],  H2O2
apors,  and  chlorine  dioxide  gas  (ClO2)  [19].
hitehead  and  McCue  [17]  showed  that  bleach
nd acid-based  disinfectants  could  inactivate  FCV
ithin 1  min  (>4  log10 reduction).  The  use  of  ClO2
as  been  shown  to  reduce  FCV  titers  by  >3  log10
ithin  10  h  [19],  and  ozone  can  inactivate  FCV  in
ess than  1  h  [18].  Some  of  these  compounds  are
oxic, energy  intensive,  and  expensive  and  require
n extended  time  for  virus  inactivation.  Ecasol  is
on-toxic,  non-corrosive,  relatively  inexpensive  to
roduce, and  biodegradable.  After  Ecasol  is  used,
nly water  (>99.8%)  and  a  small  amount  of  salt
rystals  remain  (NaCl,  <0.2%).  The  amount  of  NaCl
rystals present  is  too  low  to  corrode  metal  sur-
aces  and  can  be  easily  removed  with  water.  Thus,
e recommend  Ecasol  for  disinfecting  surfaces  con-
aminated  with  NoV.  Further  studies  are  in  progress
n the  use  of  Ecasol  for  a  number  of  delivery  meth-
ds, including  direct  application  and  fogging,  as
 disinfecting  agent  against  additional  viruses  and
acteria.
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